Condition: Viral Pneumonia · Sponsor: Synairgen Research Ltd.
The goal of this Phase 2 study is to assess about the safety, antiviral biomarker responses and efficacy of SNG001 when given to patients requiring invasive mechanical ventilation due to a respiratory virus infection. Its ability to speed up virus clearance and reduce mortality, compared with standard of care, will be studied. The study is split into two parts. All participants will receive standard of care in addition to SNG001 or placebo. In Part 1, the safety of SNG001 will be assessed. Participants of 50 years and older will receive study drug or placebo once a day for up to 14 days, whilst in hospital. In Part 2, the primary objective will be the efficacy of SNG001. Participants between 18 and 50 years with an immunocompromising condition and patients over 50 years (with or without an immunocompromising condition) will receive study drug once a day for up to 14 days, whilst in hospital.
This description comes directly from the study's public registry record.
Sophie Hemmings · +442380512800 · submissions@synairgen.com
Always discuss trial participation with your own doctor first.
| University of California - Davis | Sacramento, California, United States | Not Yet Recruiting |
| Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center | Torrance, California, United States | Recruiting |
| NCH Pulmonary Critical Care | Naples, Florida, United States | Not Yet Recruiting |
| Emory University | Atlanta, Georgia, United States | Recruiting |
| Snake River Research, PLLC | Idaho Falls, Idaho, United States | Recruiting |
| Northwestern University | Chicago, Illinois, United States | Recruiting |
| Sinai-Grace Hospital | Detroit, Michigan, United States | Recruiting |
| William Beaumont Hospital | Royal Oak, Michigan, United States | Recruiting |
| Mayo Clinic - Rochester | Rochester, Minnesota, United States | Recruiting |
| Washington University in St. Louis | St Louis, Missouri, United States | Recruiting |
| VA Western New York Healthcare system | Buffalo, New York, United States | Not Yet Recruiting |
| NYU Langone Tisch Hospital | New York, New York, United States | Not Yet Recruiting |
+ 55 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06999603